Início › Cânceres do Sangue › Distrito de Columbia › Washington
Ensaios clínicos de Cânceres do Sangue em Washington, DC
19 estudos para Cânceres do Sangue estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecrutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecrutandoFase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · a 7 mi de distância
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecrutandoFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · a 7 mi de distância
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
RecrutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Longitudinal Studies of Patient With FPDMM
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RecrutandoEstudo observacional
- The Center for Cancer and Blood Disorders, Bethesda · a 7 mi de distância
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
RecrutandoFase 1
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Recrutando
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · a 7 mi de distância
- Nih/Nhlbi, Bethesda · a 7 mi de distância
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecrutandoFase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · a 7 mi de distância
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RecrutandoEstudo observacional
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecrutandoFase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · a 7 mi de distância
Ensaios de Cânceres do Sangue em outras cidades
- Houston, TX46 estudos
- New York City, NY26 estudos
- Boston, MA25 estudos
- Baltimore, MD18 estudos
- Seattle, WA18 estudos
- Los Angeles, CA17 estudos
- Durham, NC16 estudos
- Chicago, IL15 estudos
- Philadelphia, PA14 estudos
- Columbus, OH14 estudos
- Edison, NJ13 estudos
- Baldwin Park, CA13 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Câncer de Próstata38 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Linfoma23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 7 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.